Answer
Breastfeeding should be avoided throughout Piqray (alpelisib) treatment and for at least one week after the last dose because of potential serious adverse reactions in the infant; whether alpelisib passes into human or animal milk is unknown.
Sources for this answer
- Piqray 50 mg, 150 mg and 200 mg film-coated tabletsNovartis Pharmaceuticals UK Ltd · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 12Document updated
Sources checked